Thorsten Kessler
Overview
Explore the profile of Thorsten Kessler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
5850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiebe J, Kuna C, Ibrahim T, Kufner S, Hintz I, Justenhoven P, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Feb;
PMID: 39961399
Introduction And Objectives: Long-term data after stenting of the left main coronary artery (LMCA) are scarce, especially regarding new-generation drug-eluting stents (DES). This analysis aimed to describe the 10-year clinical...
2.
Maxwell C, Bhakta N, Denniff M, Sandhu J, Kessler T, Ng L, et al.
J Mol Cell Cardiol Plus
. 2025 Feb;
11:100283.
PMID: 39895831
Despite strong causal associations with cardiovascular and metabolic disorders including coronary artery disease, hypertension, and type 2 diabetes, as well as a range of other diseases, the exact function of...
3.
Knoll K, Gross S, Fuchs P, Erben A, Hock J, von Scheidt M, et al.
Amyloid
. 2024 Dec;
32(1):54-62.
PMID: 39711243
Background: Wild-type transthyretin cardiac amyloidosis (ATTRwt) is an infiltrative disease leading to restrictive cardiomyopathy. We aimed to characterise exercise capacity in ATTRwt and to identify predictors of cardiopulmonary fitness, focusing...
4.
Cassese S, Simonetti F, Covarrubias H, Janisch M, Joner M, Kufner S, et al.
Am Heart J
. 2024 Dec;
282:1-12.
PMID: 39710352
Background: Percutaneous coronary intervention of severely calcified lesions is limited by inadequate stent expansion and poor clinical outcomes. Over the past decade, several devices and techniques have been developed for...
5.
Kruger N, Krefting J, Kessler T, Schmieder R, Starnecker F, Dutsch A, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2448389.
PMID: 39621344
Importance: In patients with acute coronary syndrome (ACS) undergoing invasive treatment, ticagrelor and prasugrel are guideline-recommended P2Y12 receptor inhibitors. The ISAR-REACT5 randomized clinical trial demonstrated superiority for prasugrel, although concerns...
6.
Trenkwalder T, Maj C, Al-Kassou B, Debiec R, Doppler S, Musameh M, et al.
JAMA Cardiol
. 2024 Nov;
10(2):145-154.
PMID: 39504041
Importance: Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist. However, it is unknown which genetic and cardiovascular risk factors might be AS-specific and which could be shared between...
7.
Wiebe J, Byrne R, Bradaric C, Kuna C, Kessler T, Pfleiderer M, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39408009
The performance of an everolimus-eluting bioresorbable scaffold (BRS) was inferior to an everolimus-eluting metallic drug-eluting stent (DES) with permanent polymer, mainly due the mechanical features of BRS technology. The performance...
8.
Dutsch A, Graesser C, Novacek S, Krefting J, Schories V, Niedermeier B, et al.
Hamostaseologie
. 2024 Oct;
PMID: 39366427
Introduction: Platelets greatly contribute to cardiovascular diseases. We sought to explore the association of platelet counts with infarct size and outcome in patients presenting with acute ST-segment elevation MI (STEMI)...
9.
Voll F, Kuna C, Scalamogna M, Kessler T, Kufner S, Rheude T, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Jun;
78(2):127-137.
PMID: 38936467
Introduction And Objectives: Multivessel percutaneous coronary intervention (MV-PCI) is recommended in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) without cardiogenic shock. The present network...
10.
Verovenko V, Tennstedt S, Kleinecke M, Kessler T, Schunkert H, Erdmann J, et al.
Sci Rep
. 2024 May;
14(1):12212.
PMID: 38806571
A positive family history is a major independent risk factor for atherosclerosis, and genetic variation is an important aspect of cardiovascular disease research. We identified a heterozygous missense variant p.L245P...